ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$5.91
-0.18 (-2.96%)
Performance
1D
—
1W
—
1M
—
3M
+19.39%
6M
+61.92%
1Y
+63.71%
YTD
+63.71%
Open$6.08
Previous Close$6.09
Day High$6.23
Day Low$5.65
52W High$6.52
52W Low$1.52
Volume—
Avg Volume2.49M
Market Cap794.69M
P/E Ratio—
EPS$-0.56
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$4.51
Above
RSI (14)
55.5
Neutral
Analyst Ratings
Strong Buy
18 analysts
Price Target
+201.0% upside
Current
$5.91
$5.91
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.98M | 12.46M | 98.24M |
| Net Income | -66,186,376 | -92,972,902 | 16.97M |
| Profit Margin | -829.6% | -788.1% | 17.3% |
| EBITDA | -77,394,452 | -114,756,874 | 25.23M |
| Free Cash Flow | — | — | 16.84M |
| Rev Growth | -35.9% | -35.9% | +7.1% |
| Debt/Equity | — | — | 1.07 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |